RN7SL753P

Across TCGA pan-cancer cohorts, RN7SL753P RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated RN7SL753P data layer.

The strongest signal is observed in prostate adenocarcinoma (PRAD), where higher RN7SL753P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL753P expression acts as an unfavorable survival marker, although some lineages such as BRCA and UCS show a favorable association.

PRAD, BRCA, and UCS are the cancer types where RN7SL753P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PRAD	OS	Tertile	All	0.967	0.995	.009	24	view →
BRCA	OS	Tertile	All	0.977	0.954	.015	21	view →
UCS	DFS	Tertile	IV	0.981	0.510	.020	18	view →
UVM	DFS	Tertile	III,IV	0.186	0.707	.027	15	view →
COAD	OS	Quartile	All	0.964	0.832	.011	15	view →
LUSC	DFS	Quartile	All	0.278	0.564	.010	13	view →
UCEC	DFS	Tertile	IV	1.000	0.388	.048	12	view →
KICH	OS	Tertile	All	0.831	0.992	.014	9	view →
SKCM	DFS	Tertile	III,IV	0.116	0.377	.002	9	view →
KIRP	DFS	Tertile	All	0.960	0.670	.037	8	view →
THCA	OS	Quartile	All	0.872	0.977	.018	7	view →
DLBC	OS	Tertile	II,III,IV	1.000	0.546	.045	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

RN7SL753P–PRAD (OS)

Open the PRAD breakdown →